{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:54:35Z","timestamp":1784595275792,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bbrep.2024.101869","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:03:40Z","timestamp":1731445420000},"page":"101869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An immortalized adipose-derived stem cells line from the PIK3CA-related overgrowth spectrum: Unveiling novel therapeutic targets"],"prefix":"10.1016","volume":"40","author":[{"given":"Bin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2024.101869_bib1","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome","volume":"90","author":"Kurek","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrep.2024.101869_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrep.2024.101869_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41431-023-01414-9","article-title":"Epidemiology of the disorders of the Pik3ca-related overgrowth spectrum (Pros)","volume":"31","author":"Reynolds","year":"2023","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrep.2024.101869_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13023-023-02786-3","article-title":"Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations","volume":"18","author":"Chen","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrep.2024.101869_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/pde.15346","article-title":"Facial infiltrating lipomatosis with hemimegalencephaly and lymphatic malformations caused by nonhotspot phosphatidylinositol 3-kinase catalytic subunit alpha mutation","volume":"40","author":"Chen","year":"2023","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.bbrep.2024.101869_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/00006534-200111000-00017","article-title":"Facial infiltrating lipomatosis","volume":"108","author":"Padwa","year":"2001","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbrep.2024.101869_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00006534-198806000-00047","article-title":"Liposuction for congenital infiltrating lipomatosis of the face","volume":"81","author":"Van Wingerden","year":"1988","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbrep.2024.101869_bib8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbrep.2024.101869_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-021-01745-0","article-title":"Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome","volume":"16","author":"Forde","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrep.2024.101869_bib10","article-title":"Clinical response to PI3K-\u03b1 inhibition in a cohort of children and adults with PIK3CA-related overgrowth spectrum disorders","volume":"3","author":"Raghavendran","year":"2022","journal-title":"J. Vasc. Anomal."},{"key":"10.1016\/j.bbrep.2024.101869_bib11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2024.101869_bib12","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.gim.2022.07.026","article-title":"Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth","volume":"24","author":"Wenger","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrep.2024.101869_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum","volume":"21","author":"Parker","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrep.2024.101869_bib14","first-page":"86","article-title":"Sirolimus in the treatment of vascular anomalies","volume":"27","author":"Triana","year":"2017","journal-title":"Eur. J. Pediatr. Surg. : Off. J. Aust. Associat. Pediat. Surg. [et al] = Zeitschrift fur Kinderchirurgie"},{"key":"10.1016\/j.bbrep.2024.101869_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10048-018-0540-1","article-title":"In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)","volume":"19","author":"Ranieri","year":"2018","journal-title":"Neurogenetics"},{"key":"10.1016\/j.bbrep.2024.101869_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123092","article-title":"Molecular and functional characterization of three different postzygotic mutations in PIK3CA-related overgrowth spectrum (PROS) patients: effects on PI3K\/AKT\/mTOR signaling and sensitivity to PIK3 inhibitors","volume":"10","author":"Loconte","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2024.101869_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2020.04.146","article-title":"Neutralization of HSF1 in cells from PIK3CA-related overgrowth spectrum patients blocks abnormal proliferation","volume":"530","author":"Da Costa","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2024.101869_bib18","doi-asserted-by":"crossref","first-page":"12e","DOI":"10.1097\/01.prs.0000436822.26709.7c","article-title":"PIK3CA activating mutations in facial infiltrating lipomatosis","volume":"133","author":"Maclellan","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbrep.2024.101869_bib19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/pr.2017.155","article-title":"Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis","volume":"82","author":"Couto","year":"2017","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbrep.2024.101869_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41419-020-02806-1","article-title":"Activating PIK3CA mutation promotes adipogenesis of adipose-derived stem cells in macrodactyly via up-regulation of E2F1","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2024.101869_bib21","article-title":"Altered adipose-derived stem cell characteristics in macrodactyly","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2024.101869_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41419-020-2723-6","article-title":"Activating PIK3CA mutation promotes osteogenesis of bone marrow mesenchymal stem cells in macrodactyly","volume":"11","author":"Cui","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2024.101869_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrep.2024.101869_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1998.4272","article-title":"SV40-Mediated immortalization","volume":"245","author":"Jha","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrep.2024.101869_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1010000132671","article-title":"Senescence and immortalization of human cells","volume":"1","author":"Duncan","year":"2000","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbrep.2024.101869_bib26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41556-018-0218-9","article-title":"Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth","volume":"20","author":"Ying","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrep.2024.101869_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/scrt452","article-title":"Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors","volume":"5","author":"Balducci","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrep.2024.101869_bib28","doi-asserted-by":"crossref","first-page":"24912","DOI":"10.1074\/jbc.M116.730093","article-title":"Chondrocyte FGFR3 regulates bone mass by inhibiting osteogenesis","volume":"291","author":"Wen","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2024.101869_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13287-023-03237-3","article-title":"Combining single-cell transcriptomics and CellTagging to identify differentiation trajectories of human adipose-derived mesenchymal stem cells","volume":"14","author":"Lin","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrep.2024.101869_bib30","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1158\/0008-5472.CAN-12-1451","article-title":"Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation","volume":"72","author":"Yi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101869_bib31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/neuonc\/noad111","article-title":"NCAPG promotes the progression of glioblastoma by facilitating PARP1-mediated E2F1 transactivation","volume":"25","author":"Hou","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrep.2024.101869_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-023-01359-x","article-title":"Intact regulation of G1\/S transition renders esophageal squamous cell carcinoma sensitive to PI3K\u03b1 inhibitors","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrep.2024.101869_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/neuonc\/noy207","article-title":"ECT2\/PSMD14\/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1","volume":"21","author":"Zhi","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrep.2024.101869_bib34","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/MCB.17.8.4761","article-title":"The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain","volume":"17","author":"Srinivasan","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2024.101869_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrep.2024.101869_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108118","article-title":"The role of the STAT3 signaling transduction pathways in radioresistance","volume":"234","author":"Shih","year":"2022","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrep.2024.101869_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrep.2024.101869_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2024.101869_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-018-0309-z","article-title":"Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression","volume":"16","author":"He","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrep.2024.101869_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrep.2024.101869_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1476-4598-9-97","article-title":"NF-kappaB\/STAT3\/PI3K signaling crosstalk in iMyc E mu B lymphoma","volume":"9","author":"Han","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrep.2024.101869_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s13402-020-00514-8","article-title":"The PI3K\/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis","volume":"43","author":"Xiao","year":"2020","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.bbrep.2024.101869_bib43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4062\/biomolther.2021.145","article-title":"Combination therapy of the active KRAS-targeting antibody inRas37 and a PI3K inhibitor in pancreatic cancer","volume":"30","author":"Lee","year":"2022","journal-title":"Biomol. & Therapeut."},{"key":"10.1016\/j.bbrep.2024.101869_bib44","doi-asserted-by":"crossref","first-page":"x3","DOI":"10.1093\/annonc\/mdz281","article-title":"Overview of the relevance of PI3K pathway in HR-positive breast cancer","volume":"30","author":"Vasan","year":"2019","journal-title":"Ann. Oncol. : Off. J. Euro. Soc. Med. Oncol."},{"key":"10.1016\/j.bbrep.2024.101869_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10565-020-09523-7","article-title":"Roles of TP53 gene in the development of resistance to PI3K inhibitor resistances in CRISPR-Cas9-edited lung adenocarcinoma cells","volume":"36","author":"Hou","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbrep.2024.101869_bib46","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1158\/2159-8290.CD-16-0305","article-title":"Systematic functional characterization of resistance to PI3K inhibition in breast cancer","volume":"6","author":"Le","year":"2016","journal-title":"Cancer Discov."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824002334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824002334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T14:23:29Z","timestamp":1733235809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580824002334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S2405580824002334"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101869","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An immortalized adipose-derived stem cells line from the PIK3CA-related overgrowth spectrum: Unveiling novel therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101869"}}